RemeGen Biosciences
Xiaoshan Min is an experienced biophysicist currently serving as Executive Director at RemeGen Biosciences since September 2020, where responsibilities include formulating and executing strategies for early discovery research and leading multiple projects from target selection to IND submission. Previously, at Amgen from 2006 to September 2020, Xiaoshan held positions including Principal Scientist, leading structural biology efforts across three therapeutic areas, and Senior Scientist, managing structural biology support for various projects. Xiaoshan began the professional journey with a Ph.D. in biophysics from UT Southwestern Medical Center, following a Master’s degree in biophysics from the Chinese Academy of Sciences and a Bachelor’s degree from Wuhan University.
This person is not in any teams
RemeGen Biosciences
1 followers
RemeGen is a global biopharmaceutical company, focusing on the discovery, development and commercialization of novel biologics for the treatment of autoimmune, oncology and ophthalmic diseases with significant unmet medical needs. RemeGen Biosciences, a wholly owned subsidiary of RemeGen, is based in South San Francisco, California, the birthplace of biotechnology and in Maryland. Our vision is to create the first-in-class and/or best-in-class biotherapeutics with innovative target discovery strategies, advanced molecule design and protein engineering platforms. Our passion is to serve patients with more effective therapies in a timely manner.